Cargando…
Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify disease into molecularly defined subtypes to examine associations with etiologic risk factors and prognosis. The aim of this study was to provide a comprehensive analysis of VHL inactivation in clear cell rena...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192834/ https://www.ncbi.nlm.nih.gov/pubmed/22022277 http://dx.doi.org/10.1371/journal.pgen.1002312 |
_version_ | 1782213805538803712 |
---|---|
author | Moore, Lee E. Nickerson, Michael L. Brennan, Paul Toro, Jorge R. Jaeger, Erich Rinsky, Jessica Han, Summer S. Zaridze, David Matveev, Vsevolod Janout, Vladimir Kollarova, Hellena Bencko, Vladimir Navratilova, Marie Szeszenia-Dabrowska, Neonilia Mates, Dana Schmidt, Laura S. Lenz, Petra Karami, Sara Linehan, W. Marston Merino, Maria Chanock, Stephen Boffetta, Paolo Chow, Wong-Ho Waldman, Frederic M. Rothman, Nathaniel |
author_facet | Moore, Lee E. Nickerson, Michael L. Brennan, Paul Toro, Jorge R. Jaeger, Erich Rinsky, Jessica Han, Summer S. Zaridze, David Matveev, Vsevolod Janout, Vladimir Kollarova, Hellena Bencko, Vladimir Navratilova, Marie Szeszenia-Dabrowska, Neonilia Mates, Dana Schmidt, Laura S. Lenz, Petra Karami, Sara Linehan, W. Marston Merino, Maria Chanock, Stephen Boffetta, Paolo Chow, Wong-Ho Waldman, Frederic M. Rothman, Nathaniel |
author_sort | Moore, Lee E. |
collection | PubMed |
description | Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify disease into molecularly defined subtypes to examine associations with etiologic risk factors and prognosis. The aim of this study was to provide a comprehensive analysis of VHL inactivation in clear cell renal tumors (ccRCC) and to evaluate relationships between VHL inactivation subgroups with renal cancer risk factors and VHL germline single nucleotide polymorphisms (SNPs). VHL genetic and epigenetic inactivation was examined among 507 sporadic RCC/470 ccRCC cases using endonuclease scanning and using bisulfite treatment and Sanger sequencing across 11 CpG sites within the VHL promoter. Case-only multivariate analyses were conducted to identify associations between alteration subtypes and risk factors. VHL inactivation, either through sequence alterations or promoter methylation in tumor DNA, was observed among 86.6% of ccRCC cases. Germline VHL SNPs and a haplotype were associated with promoter hypermethylation in tumor tissue (OR = 6.10; 95% CI: 2.28–16.35, p = 3.76E-4, p-global = 8E-5). Risk of having genetic VHL inactivation was inversely associated with smoking due to a higher proportion of wild-type ccRCC tumors [former: OR = 0.70 (0.20–1.31) and current: OR = 0.56 (0.32–0.99); P-trend = 0.04]. Alteration prevalence did not differ by histopathologic characteristics or occupational exposure to trichloroethylene. ccRCC cases with particular VHL germline polymorphisms were more likely to have VHL inactivation through promoter hypermethylation than through sequence alterations in tumor DNA, suggesting that the presence of these SNPs may represent an example of facilitated epigenetic variation (an inherited propensity towards epigenetic variation) in renal tissue. A proportion of tumors from current smokers lacked VHL alterations and may represent a biologically distinct clinical entity from inactivated cases. |
format | Online Article Text |
id | pubmed-3192834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31928342011-10-21 Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors Moore, Lee E. Nickerson, Michael L. Brennan, Paul Toro, Jorge R. Jaeger, Erich Rinsky, Jessica Han, Summer S. Zaridze, David Matveev, Vsevolod Janout, Vladimir Kollarova, Hellena Bencko, Vladimir Navratilova, Marie Szeszenia-Dabrowska, Neonilia Mates, Dana Schmidt, Laura S. Lenz, Petra Karami, Sara Linehan, W. Marston Merino, Maria Chanock, Stephen Boffetta, Paolo Chow, Wong-Ho Waldman, Frederic M. Rothman, Nathaniel PLoS Genet Research Article Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify disease into molecularly defined subtypes to examine associations with etiologic risk factors and prognosis. The aim of this study was to provide a comprehensive analysis of VHL inactivation in clear cell renal tumors (ccRCC) and to evaluate relationships between VHL inactivation subgroups with renal cancer risk factors and VHL germline single nucleotide polymorphisms (SNPs). VHL genetic and epigenetic inactivation was examined among 507 sporadic RCC/470 ccRCC cases using endonuclease scanning and using bisulfite treatment and Sanger sequencing across 11 CpG sites within the VHL promoter. Case-only multivariate analyses were conducted to identify associations between alteration subtypes and risk factors. VHL inactivation, either through sequence alterations or promoter methylation in tumor DNA, was observed among 86.6% of ccRCC cases. Germline VHL SNPs and a haplotype were associated with promoter hypermethylation in tumor tissue (OR = 6.10; 95% CI: 2.28–16.35, p = 3.76E-4, p-global = 8E-5). Risk of having genetic VHL inactivation was inversely associated with smoking due to a higher proportion of wild-type ccRCC tumors [former: OR = 0.70 (0.20–1.31) and current: OR = 0.56 (0.32–0.99); P-trend = 0.04]. Alteration prevalence did not differ by histopathologic characteristics or occupational exposure to trichloroethylene. ccRCC cases with particular VHL germline polymorphisms were more likely to have VHL inactivation through promoter hypermethylation than through sequence alterations in tumor DNA, suggesting that the presence of these SNPs may represent an example of facilitated epigenetic variation (an inherited propensity towards epigenetic variation) in renal tissue. A proportion of tumors from current smokers lacked VHL alterations and may represent a biologically distinct clinical entity from inactivated cases. Public Library of Science 2011-10-13 /pmc/articles/PMC3192834/ /pubmed/22022277 http://dx.doi.org/10.1371/journal.pgen.1002312 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Moore, Lee E. Nickerson, Michael L. Brennan, Paul Toro, Jorge R. Jaeger, Erich Rinsky, Jessica Han, Summer S. Zaridze, David Matveev, Vsevolod Janout, Vladimir Kollarova, Hellena Bencko, Vladimir Navratilova, Marie Szeszenia-Dabrowska, Neonilia Mates, Dana Schmidt, Laura S. Lenz, Petra Karami, Sara Linehan, W. Marston Merino, Maria Chanock, Stephen Boffetta, Paolo Chow, Wong-Ho Waldman, Frederic M. Rothman, Nathaniel Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title_full | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title_fullStr | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title_full_unstemmed | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title_short | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors |
title_sort | von hippel-lindau (vhl) inactivation in sporadic clear cell renal cancer: associations with germline vhl polymorphisms and etiologic risk factors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192834/ https://www.ncbi.nlm.nih.gov/pubmed/22022277 http://dx.doi.org/10.1371/journal.pgen.1002312 |
work_keys_str_mv | AT mooreleee vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT nickersonmichaell vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT brennanpaul vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT torojorger vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT jaegererich vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT rinskyjessica vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT hansummers vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT zaridzedavid vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT matveevvsevolod vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT janoutvladimir vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT kollarovahellena vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT benckovladimir vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT navratilovamarie vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT szeszeniadabrowskaneonilia vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT matesdana vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT schmidtlauras vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT lenzpetra vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT karamisara vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT linehanwmarston vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT merinomaria vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT chanockstephen vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT boffettapaolo vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT chowwongho vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT waldmanfredericm vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors AT rothmannathaniel vonhippellindauvhlinactivationinsporadicclearcellrenalcancerassociationswithgermlinevhlpolymorphismsandetiologicriskfactors |